Sphere Fluidics announces enhanced Cyto-Mine capability and performance
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced it has enhanced […]
» Read moreResearchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses […] Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard […] Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody […] People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune […] The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […] The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, […] Extensive testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a primary mitigation measure in controlling […] As the numbers of those infected with COVID-19 has continued to climb, the desperate need for a vaccine was apparent. […] An investigational anti-HIV antibody delivered intravenously once every eight weeks safely and effectively prevented acquisition of HIV strains sensitive to […]
Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages
Scientists unveil new Ebola virus vaccine design
FDA revokes EUA for monoclonal antibody therapy bamlanivimab to treat patients with COVID-19
Recovered COVID-19 patients may need only a single vaccine dose, suggests study
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function
Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies
Holonyak lab team creates fast, cheap, accessible COVID-19 antibody test
Antibody infusions prevent acquisition of some HIV strains, studies find
